(Q37995322)

26 August 2017

title

Micronized progesterone and its impact on the endometrium and breast vs. progestogens (English)

1 reference

26 August 2017

A Gompel

1

1 reference

26 August 2017

publication date

1 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

15 Suppl 1

1 reference

26 August 2017

page(s)

18-25

1 reference

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Morphological changes in breast tissue with menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Breast cancer risk in postmenopausal women using estradiol-progestogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Transcriptional profiles of progestogen effects in the postmenopausal breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Control of mammary stem cell function by steroid hormone signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2012.669584

10.3109/13697137.2012.669584

21 January 2018

Identifiers

DOI

1 reference

release_axfasmwpeff3lgkbjbirhxocsy

26 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/axfasmwpeff3lgkbjbirhxocsy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference